Genomics and human genetics are rapidly becoming attractive industries that also play an important role in advancing scientific knowledge. Increases in public and non-profit research funding, as well as commercial support for biotechnology and pharmaceutical R&D, contributed to the rise of these disciplines. The story's focus on DNA patents shows how the law has changed to accommodate (or ignore) developments in genomics